Professional Documents
Culture Documents
A1 GC Poster Template (Landscape) (2) - 副本
A1 GC Poster Template (Landscape) (2) - 副本
People:
4 Active interest and signs of a more open mind are shown to assess the possible
1 benefits of phage therapy(8).
Clinical trials:
•To demonstrate the efficacy and safety of phage application(8).
2 •National and international authorities are opening their doors to such trials, and
3 are prone to regulate phage therapy if it is found to be effective and safe(8).
References
1. Kortright KE, Chan BK, Koff JL, Turner PE. Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria. Cell Host Microbe. 2019 Feb 13;25(2):219–32.
2. Antibiotic resistance [Internet]. [cited 2021 Apr 17]. Available from: https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance
3. Bacteriophage: Structure, Replication and Uses - Learn Microbiology Online [Internet]. [cited 2021 Apr 18]. Available from: https://microbeonline.com/bacteriophage-structure-replication-use/
4. Bacteriophage: A solution to our antibiotics problem? How we can us a virus to fight bacterial infection [Internet]. [cited 2021 Apr 18]. Available from: https://sitn.hms.harvard.edu/flash/2018/bacteriophage-solution-antibiotics-problem/
5. Viruses [Internet]. [cited 2021 Apr 18]. Available from: https://cronodon.com/BioTech/Virus_Tech.html
Figure 2; the structure of phage T4(5) 6. Gurney J, Brown SP, Kaltz O, Hochberg ME. Steering phages to combat bacterial pathogens. Trends Microbiol. 2020 Feb;28(2):85–94.
7. Gordillo Altamirano FL, Barr JJ. Phage Therapy in the Postantibiotic Era. Clin Microbiol Rev [Internet]. 2019 Jan 16 [cited 2021 Apr 18];32(2). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431132/
8. Górski A, Międzybrodzki R, Łobocka M, Głowacka-Rutkowska A, Bednarek A, Borysowski J, et al. Phage Therapy: What Have We Learned? Viruses. 2018 Jun;10(6):288.